People · Operator
Named in public records as an officer, director or promoter · active 2013–2017 · Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Jaguar Health, Inc. | — | Pharmaceuticals | Series C | $151.1M | $58.9M | 2013 |
| Nuelle, Inc. | — | Other Health Care | Series B | $36.6M | $156.2M | 2014 |
Zhi Yang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Zhi Yang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ryan Drant | 1 | 24 |
| John Nehra | 1 | 11 |
| Joshua Makower | 1 | 10 |
| Steven King | 1 | 6 |
| James J. Bochnowski | 1 | 5 |
| Anula Jayasuriya | 1 | 5 |
| Jonathan Siegel | 1 | 5 |
| John Kallassy | 1 | 4 |
| James Bochnowski | 1 | 4 |
| Pravin Chaturvedi | 1 | 4 |
| Serge Martinod | 1 | 3 |
| Lisa Conte | 1 | 3 |
| Yi Li | 1 | 3 |
| Ari Azhir | 1 | 3 |
| Jeffery Johnson | 1 | 2 |
| Karen S. Wright | 1 | 2 |
| Jonathan Wolin | 1 | 2 |
| Carol Lizak | 1 | 2 |
| Charles Thompson | 1 | 2 |
| John Micek III | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.